Factors Associated with Treatment Satisfaction in Korean Patients with Psoriasis
Sungwon Jung,David Suh,Seung-Mi Lee
DOI: https://doi.org/10.2147/ppa.s485512
2024-10-04
Patient Preference and Adherence
Abstract:Sungwon Jung, 1 David Suh, 2 Seung-Mi Lee 3 1 College of Pharmacy, Sookmyung Women's University, Seoul, 04310, Republic of Korea; 2 School of Public Health, University of Michigan, Ann Arbor, MI, 48109, USA; 3 College of Pharmacy, Daegu Catholic University, Gyeongsan, 38430, Republic of Korea Correspondence: Seung-Mi Lee, College of Pharmacy, Daegu Catholic University, Gyeongsan, 38430, Republic of Korea, Tel +82-53-850-3608, Email Purpose: Treatment satisfaction among patients with psoriasis can vary significantly based on available treatment options and individual patient characteristics. Patients and Methods: This cross-sectional study utilized psoriasis-specific questionnaires to assess treatment satisfaction and identify the factors associated with treatment satisfaction in Korean patients. The study included 350 eligible patients aged 19 or older from a nationwide psoriasis group. Participants completed a self-reported web-based questionnaire assessing socioeconomic and clinical status, quality of life, and treatment satisfaction. Linear regression models were employed to analyze the factors associated with treatment satisfaction. Results: The results showed that patients with mild to moderate psoriasis, as determined by the body surface area involvement, had higher satisfaction scores for treatment effectiveness. Moreover, patients receiving biologic therapies reported significantly higher total satisfaction scores and scores across all domains than those not utilizing biologics. However, patients reporting poorer quality of life or experiencing anxiety exhibited lower satisfaction scores. Conclusion: Findings suggest that while biologic treatments may confer greater satisfaction to patients with psoriasis, diminished quality of life and anxiety can negatively impact satisfaction levels. The study underscores the importance of understanding the factors associated with patient satisfaction to optimize treatment outcomes in psoriasis management. Keywords: patient satisfaction, psoriasis, biologics, treatment types, quality of life Psoriasis, a chronic, immune-mediated inflammatory skin disease, affects approximately 0.4% of the Korean population and has a global prevalence of around 3% among adults. 1–4 This condition is associated with comorbidities such as cardiovascular diseases, metabolic syndrome, anxiety, and depression that adversely affect physical functions and quality of life (QoL). 5,6 Cultural factors are critical in how societies perceive and manage skin diseases like psoriasis. While Western countries often focus on clinical treatment, in Korea and other Eastern Asian cultures, clear skin is viewed as a marker of health and social status. 7 This cultural emphasis on flawless skin intensifies stigma, leading to psychological distress and social isolation for those with visible conditions. 8,9 These cultural differences also influence patients' treatment responses and QoL, underscoring the need for culturally tailored approaches to care. 10 Treatment options for patients with psoriasis include topical medication, phototherapy, systemic therapeutics, and, most recently, biologic treatment. 11 The guidelines for psoriasis treatment recommend topical corticosteroids as first-line treatment for mild to moderate plaque psoriasis or as part of a treatment regimen for more severe cases. 12 Clinical trials and real-world data have demonstrated that biologic drugs targeting proinflammatory cytokines provide clinical benefits in managing severe psoriasis. 13–16 However, access to biologics, such as tumor necrosis factor (TNF)-alpha inhibitors and interleukin (IL)-12/23 inhibitors, is limited due to their high cost. A study using health insurance claim data in Korea reported that 88% of patients with psoriasis were untreated or treated topically, and only 3% of patients receiving systemic treatment were treated with biologics. Moreover, patients with low socioeconomic status are less likely to receive expensive biologic therapies. 17 As psoriasis requires long-term treatment and regular follow-up visits, patient satisfaction with their treatment is a critical determinant of compliance and health outcomes. In addition, various factors, including treatment options, disease duration, and comorbidities, influence patient treatment satisfaction. 18 Studies have reported nonadherence and frustration among patients undergoing treatment for psoriasis, in addition to poor satisfaction with treatments. 19,20 Higher patient satisfaction with treatment can improve health-related QoL (HRQoL), while low patient satisfaction can lead to poor adherence to the trea -Abstract Truncated-
medicine, general & internal